Variable Patients (n=22)
LAA epicardial device Lariat AtriClip 72.7% (n=16) 27.3% (n=6)
Age, years (Mean ± SD) 68.2 ± 8.5
Female 45.5% (n=10)
BMI (Mean ± SD) [kg/m2] 28.7 ± 2.7
Left Ventricle Ejection Fraction (LVEF) (%) 54.5 ± 6.2
CHADS2 score (Mean ± SD) 2.8±1.1
CHA2DS2- VASs score (Mean ± SD) 4.3±1.7
HAS-BLED score ( Mean ± SD ) 3.5±1.3
Congestive Heart Failure 9.1% (n=2)
Hypertension 95% (n=21)
Hyperlipidemia 59.1% (n=13)
Diabetes Mellitus 2 31.8% (n=7)
Previous ischemic stroke/TIA 72.7% (n=16)
Hemorrhagic stroke 9.1% (n=2)
Myocardial infraction 4.5% (n=1)
Vascular Disease 9.1% (n=2)
Alcoholism 9.1% (n=2)
Laboratory parameters Platelet count (103) PT-INR PT sec PT % APTT (sek) Anti-Xa activity (IU/mL) C-reactive protein (mg/L) Total cholesterol (mmol/L) LDL cholesterol (mmol/L) HDL cholesterol (mmol/L) Triglyceride (mmol/L) Glycated hemoglobin (HBA1C) (%) 241.9±24 1.2±0.3 13.1±2.5 81.3±21.5 35.9±7.8 0.5±0.3 1.7±1.7 4.2±1.0 2.5±1.0 1.3±0.4 1.7±1.1 5.9±0.8